MétaCan
Menu
← Back to cohort

Do women younger than 40 treated in the hormone-therapy era benefit from a radiotherapy boost as a part of adjuvant breast radiotherapy?

2014· article· en· W2273510718 on OpenAlexaff
Scott Tyldesley, Elisa Chan, Caroline Speers, Alan Nichol

Bibliographic record

VenueJournal of Clinical Oncology · 2014
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBreast Cancer Treatment Studies
Canadian institutionsSaint John Regional HospitalBC Cancer Agency
Fundersnot available
KeywordsMedicineRadiation therapyLumpectomyLymphovascular invasionBreast cancerPopulationMastectomyHormonal therapyOncologyBreast-conserving surgeryInternal medicineCancerGynecologyMetastasis

Abstract

fetched live from OpenAlex

72 Background: The EORTC 22881 trial showed a 10% reduction in local relapse with a radiotherapy boost (RTB) after breast conserving therapy (BCT) among women ≤40 years old. However no premenopausal patients received hormone therapy (HT) in this study. A policy change in December 1998 recommended the use of HT after chemotherapy for premenopausal ER positive women. A second policy change in December 2001 recommended an RTB after BCT for women ≤40 years old. The purpose of our study was to describe: 1)how the use of HT and RTB after BCT changed after practice guidelines were implemented in a population-based cancer care program; and 2) how local relapse rates (LRR) changed after these policy changes. Methods: A provincial database was used to analyse all women ≤ 40 years old referred for consideration of radiotherapy with margin negative stage 1 and 2 (≤3 nodes positive) breast cancer, treated with lumpectomy and whole breast radiotherapy. Cases were grouped into three eras according to policy transition with 3 month gaps: 1) Jan 1996-Sep 1998, 2) Jan 1999-Sep 2001, 3) Jan 2002 to Sep 2004. Changes in the use of HT and RTB over these eras were assessed. Eight year LR-free survival was calculated using the Kaplan-Meier method and the three eras compared using log rank tests. Multivariable analysis (MVA) was performed including era, size of tumour, nodal status (0 vs 1-3), grade, lymphovascular space invasion (LVI), and use of chemotherapy. Results: There were 130 eligible patients from Era 1, 145 patients from Era 2, and 140 patients from Era 3. ER status did not differ across eras. HT was used for ER positive patients in 13% of Era 1, 68% of Era 2, and 83% of Era 3 cases (p<0.001). RTB was used in 40% of Era 1, 28% of Era 2, and 77% of Era 3 patients (p<0.001). LRR at 8 years were 87.3% Era 1, 94.8 % Era 2, and 94.5% Era 3 (p=0.03). Era (used as surrogate for transitions in the use of HT and RTB) remained significant on MVA (0=0.008). Conclusions: Patterns of use of HT and RTB changed after policy changes. The benefit of adding a boost in women ≤40 years old shown by the EORTC was not observed after the introduction of routine HT at a population level.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.027
Threshold uncertainty score0.054

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.034
GPT teacher head0.367
Teacher spread0.333 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicBreast Cancer Treatment Studies→French-language works237,207→